Wilson Sonsini is proud to sponsor the BioFuture New York 2024 conference. This year’s event will be a melting pot of cross-industry ideas and insights that fuse the swiftly developing fields of biopharma, digital medicine, big data, artificial intelligence, healthcare systems, insurance providers, and beyond.

On Monday October 28th, Wilson Sonsini partner Seth Flaum will join a Panel on the Biosecure Act: Balancing Security and Innovation in Biotechnology. Other Panelists include Max Bayer, Pharma Reporter for Endpoints News; Greg Simon, President of Simonovation, LLC; and Arda Ural, Americas Life Sciences Leader at Ernst & Young LLP.

Later in the day, Seth will moderate a panel on Navigating New Horizons: Unlocking Opportunities in TechBio.

Panelists will include: Konstantina Katcheves, Senior Vice President, Innovation Medicines Business Development and Acquisitions at Teva Pharmaceuticals; Daniella Kranjac, Founding GP at Avant Bio; Viq Pervaaz, Senior Vice President at New York City Economic Development Corporation; and Ajit Singh, Partner at Artiman Ventures.